17-(1′propenyl)-17-3′-oxidoestra-4-en-3-one derivative, use thereof, and medicament containing said derivative

The invention relates to 17-(1′-propenyl)-17-3′-oxidoestra-4-en-3-one derivatives with the general chemical formula I, where the residues Z, R4, R6a, R6b, R7, R15, R16a, R16b and R18 have the meanings stated in Claim 1, and their solvates, hydrates and salts, including all stereoisomers of these com...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: MENGES FREDERIK, KUHNKE JOACHIM, RING SVEN, FRENZEL THOMAS, PRELLE KATJA, BOHLMANN ROLF, HÜBNER JAN, KLAR ULRICH, MUHN HANS PETER, BORDEN STEFFEN
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator MENGES FREDERIK
KUHNKE JOACHIM
RING SVEN
FRENZEL THOMAS
PRELLE KATJA
BOHLMANN ROLF
HÜBNER JAN
KLAR ULRICH
MUHN HANS PETER
BORDEN STEFFEN
description The invention relates to 17-(1′-propenyl)-17-3′-oxidoestra-4-en-3-one derivatives with the general chemical formula I, where the residues Z, R4, R6a, R6b, R7, R15, R16a, R16b and R18 have the meanings stated in Claim 1, and their solvates, hydrates and salts, including all stereoisomers of these compounds. The invention further relates to the use of these derivatives for the production of a medicinal product for oral contraception and for the treatment of pre-, peri- and postmenopausal complaints and medicinal products that contain said derivatives, and in particular application in the aforementioned indications. The derivatives according to the invention have a progestational and in preferred cases additionally an antimineralocorticoid and neutral to slightly androgenic action.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US9034856B2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US9034856B2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US9034856B23</originalsourceid><addsrcrecordid>eNqNizsKwkAQQNNYiHqHKRUyYNz4axXFXq3DkJ3oQjK77K5BO8_kkTyJKSwsrR483usnPlviOHs_X85bx_KoJ9gZ1Qm0d6Mth-gJc2RBhVYYNHvTUjQtp3ALDPHKnm2VAomGhrUpqWGJUFqJZMTIBQIZ_fMNk15FdeDRl4ME9rvT9oDsbMHBUcnCsTgf11OVr-aLzUz9kXwAKh5Dig</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>17-(1′propenyl)-17-3′-oxidoestra-4-en-3-one derivative, use thereof, and medicament containing said derivative</title><source>esp@cenet</source><creator>MENGES FREDERIK ; KUHNKE JOACHIM ; RING SVEN ; FRENZEL THOMAS ; PRELLE KATJA ; BOHLMANN ROLF ; HÜBNER JAN ; KLAR ULRICH ; MUHN HANS PETER ; BORDEN STEFFEN</creator><creatorcontrib>MENGES FREDERIK ; KUHNKE JOACHIM ; RING SVEN ; FRENZEL THOMAS ; PRELLE KATJA ; BOHLMANN ROLF ; HÜBNER JAN ; KLAR ULRICH ; MUHN HANS PETER ; BORDEN STEFFEN</creatorcontrib><description>The invention relates to 17-(1′-propenyl)-17-3′-oxidoestra-4-en-3-one derivatives with the general chemical formula I, where the residues Z, R4, R6a, R6b, R7, R15, R16a, R16b and R18 have the meanings stated in Claim 1, and their solvates, hydrates and salts, including all stereoisomers of these compounds. The invention further relates to the use of these derivatives for the production of a medicinal product for oral contraception and for the treatment of pre-, peri- and postmenopausal complaints and medicinal products that contain said derivatives, and in particular application in the aforementioned indications. The derivatives according to the invention have a progestational and in preferred cases additionally an antimineralocorticoid and neutral to slightly androgenic action.</description><language>eng</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; STEROIDS</subject><creationdate>2015</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20150519&amp;DB=EPODOC&amp;CC=US&amp;NR=9034856B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20150519&amp;DB=EPODOC&amp;CC=US&amp;NR=9034856B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>MENGES FREDERIK</creatorcontrib><creatorcontrib>KUHNKE JOACHIM</creatorcontrib><creatorcontrib>RING SVEN</creatorcontrib><creatorcontrib>FRENZEL THOMAS</creatorcontrib><creatorcontrib>PRELLE KATJA</creatorcontrib><creatorcontrib>BOHLMANN ROLF</creatorcontrib><creatorcontrib>HÜBNER JAN</creatorcontrib><creatorcontrib>KLAR ULRICH</creatorcontrib><creatorcontrib>MUHN HANS PETER</creatorcontrib><creatorcontrib>BORDEN STEFFEN</creatorcontrib><title>17-(1′propenyl)-17-3′-oxidoestra-4-en-3-one derivative, use thereof, and medicament containing said derivative</title><description>The invention relates to 17-(1′-propenyl)-17-3′-oxidoestra-4-en-3-one derivatives with the general chemical formula I, where the residues Z, R4, R6a, R6b, R7, R15, R16a, R16b and R18 have the meanings stated in Claim 1, and their solvates, hydrates and salts, including all stereoisomers of these compounds. The invention further relates to the use of these derivatives for the production of a medicinal product for oral contraception and for the treatment of pre-, peri- and postmenopausal complaints and medicinal products that contain said derivatives, and in particular application in the aforementioned indications. The derivatives according to the invention have a progestational and in preferred cases additionally an antimineralocorticoid and neutral to slightly androgenic action.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>STEROIDS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2015</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNizsKwkAQQNNYiHqHKRUyYNz4axXFXq3DkJ3oQjK77K5BO8_kkTyJKSwsrR483usnPlviOHs_X85bx_KoJ9gZ1Qm0d6Mth-gJc2RBhVYYNHvTUjQtp3ALDPHKnm2VAomGhrUpqWGJUFqJZMTIBQIZ_fMNk15FdeDRl4ME9rvT9oDsbMHBUcnCsTgf11OVr-aLzUz9kXwAKh5Dig</recordid><startdate>20150519</startdate><enddate>20150519</enddate><creator>MENGES FREDERIK</creator><creator>KUHNKE JOACHIM</creator><creator>RING SVEN</creator><creator>FRENZEL THOMAS</creator><creator>PRELLE KATJA</creator><creator>BOHLMANN ROLF</creator><creator>HÜBNER JAN</creator><creator>KLAR ULRICH</creator><creator>MUHN HANS PETER</creator><creator>BORDEN STEFFEN</creator><scope>EVB</scope></search><sort><creationdate>20150519</creationdate><title>17-(1′propenyl)-17-3′-oxidoestra-4-en-3-one derivative, use thereof, and medicament containing said derivative</title><author>MENGES FREDERIK ; KUHNKE JOACHIM ; RING SVEN ; FRENZEL THOMAS ; PRELLE KATJA ; BOHLMANN ROLF ; HÜBNER JAN ; KLAR ULRICH ; MUHN HANS PETER ; BORDEN STEFFEN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US9034856B23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2015</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>STEROIDS</topic><toplevel>online_resources</toplevel><creatorcontrib>MENGES FREDERIK</creatorcontrib><creatorcontrib>KUHNKE JOACHIM</creatorcontrib><creatorcontrib>RING SVEN</creatorcontrib><creatorcontrib>FRENZEL THOMAS</creatorcontrib><creatorcontrib>PRELLE KATJA</creatorcontrib><creatorcontrib>BOHLMANN ROLF</creatorcontrib><creatorcontrib>HÜBNER JAN</creatorcontrib><creatorcontrib>KLAR ULRICH</creatorcontrib><creatorcontrib>MUHN HANS PETER</creatorcontrib><creatorcontrib>BORDEN STEFFEN</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>MENGES FREDERIK</au><au>KUHNKE JOACHIM</au><au>RING SVEN</au><au>FRENZEL THOMAS</au><au>PRELLE KATJA</au><au>BOHLMANN ROLF</au><au>HÜBNER JAN</au><au>KLAR ULRICH</au><au>MUHN HANS PETER</au><au>BORDEN STEFFEN</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>17-(1′propenyl)-17-3′-oxidoestra-4-en-3-one derivative, use thereof, and medicament containing said derivative</title><date>2015-05-19</date><risdate>2015</risdate><abstract>The invention relates to 17-(1′-propenyl)-17-3′-oxidoestra-4-en-3-one derivatives with the general chemical formula I, where the residues Z, R4, R6a, R6b, R7, R15, R16a, R16b and R18 have the meanings stated in Claim 1, and their solvates, hydrates and salts, including all stereoisomers of these compounds. The invention further relates to the use of these derivatives for the production of a medicinal product for oral contraception and for the treatment of pre-, peri- and postmenopausal complaints and medicinal products that contain said derivatives, and in particular application in the aforementioned indications. The derivatives according to the invention have a progestational and in preferred cases additionally an antimineralocorticoid and neutral to slightly androgenic action.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US9034856B2
source esp@cenet
subjects CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
STEROIDS
title 17-(1′propenyl)-17-3′-oxidoestra-4-en-3-one derivative, use thereof, and medicament containing said derivative
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T05%3A52%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=MENGES%20FREDERIK&rft.date=2015-05-19&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS9034856B2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true